Peregrine Pharma (PPHM) Posts Q2 Loss of 6c, Wider Than Estimated
More News related to PPHM
- Peregrine Pharmaceuticals Inc. (PPHM) Posts Q4 Loss of $0.03, Narrower than Views
- Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter Fiscal Year 2010
- Peregrine Pharmaceuticals to Report Third Quarter FY 2010 Financial Results
- New Scientific Publication Highlights Long-Term Survival of Brain Cancer Patients Treated With Peregrine Pharmaceuticals' Cotara(R)
- Peregrine Pharmaceuticals to Present at the 12th Annual BIO CEO and Investor Conference
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) reports Q2 loss of $0.06, versus the analyst estimate of ($0.01). Revenue for the quarter was $6.90 million, which compares to the estimate of $6.39 million.
Related Categories
EarningsStocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
